Target intelligence / Profile preview

CHSY3 antisense RNA 1 (CHSY3-AS1)

Target
CHSY3-AS1
Molecular classification
Antisense RNA, long non-coding RNA (lncRNA)
01

Overview

CHSY3 antisense RNA 1 (CHSY3-AS1) is a putative long non-coding RNA thought to be transcribed in the antisense direction relative to the CHSY3 gene. Antisense RNAs generally function by regulating the expression of their sense gene through transcriptional or post-transcriptional mechanisms, including affecting mRNA stability, translation, and chromatin structure. However, CHSY3-AS1 is not described in scientific literature or major molecular databases, is not recognized as a therapeutic target, and there are no data about its biological function, disease associations, or involvement in drug interactions. Its annotation may be speculative, incomplete, or incorrect, and care should be taken not to confuse it with the CHSY3 protein-coding gene, which is a validated enzyme involved in chondroitin sulfate synthesis and cancer biology. For structured datasets, CHSY3-AS1 should be flagged as potentially incorrect or lacking supporting evidence as a valid molecular target.

02

Mechanism of action

Not defined; general antisense RNAs can regulate their sense gene via transcript stability, translation repression, or epigenetic effects, but this has not been shown for CHSY3-AS1.

03

Biological functions

The biological functions of CHSY3-AS1 are uncharacterized. General lncRNAs and antisense RNAs may regulate gene expression through RNA-RNA, RNA-DNA, or RNA-protein interactions, but no specific data for CHSY3-AS1 exist.

Beyond the preview

Go deeper on CHSY3 antisense RNA 1 (CHSY3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CHSY3 antisense RNA 1 (CHSY3-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call